Ad
related to: CAH Stock
Search results
Why Cardinal Health (CAH) is a Top Value Stock for the Long-Term
Zacks via Yahoo Finance· 18 hours agoWhether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the...
Apollon Wealth Management LLC Has $411,000 Stock Position in Cardinal Health, Inc. (NYSE:CAH)
ETF DAILY NEWS· 23 hours agoApollon Wealth Management LLC grew its position in Cardinal Health, Inc. (NYSE:CAH – Free Report) by 34.0% during the 4th quarter, according to the company in its most recent ...
Selling Buzz: Cardinal Health, Inc. [CAH] CEO, Pharmaceutical Segment WEITZMAN DEBORAH sells 36,642...
Knox Daily· 4 days agoEarlier on December 14, 2023, Wells Fargo initiated its rating. Their recommendation was “an Underweight” for CAH stock. Analyzing CAH
National Bank of Canada FI Sells 106,883 Shares of Cardinal Health, Inc. (NYSE:CAH)
ETF DAILY NEWS· 4 days agoNational Bank of Canada FI lessened its stake in shares of Cardinal Health, Inc. (NYSE:CAH – Free Report) by 57.3% during the 4th quarter, according to its most recent 13F ...
Fisher Asset Management LLC Raises Holdings in Cardinal Health, Inc. (NYSE:CAH)
ETF DAILY NEWS· 3 days ago(NYSE:CAH – Free Report) by 40.1% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 4,218 shares of ...
How Neurocrine Is Stacking Up Wins In 2024 — And Outperforming Peers
Investor's Business Daily· 5 days agoBiotech Stock Jumps On Crinecerfont Filings Specifically, Neurocrine Biosciences...analyst Laura...
Atria Wealth Solutions Inc. Takes $214,000 Position in BridgeBio Pharma, Inc. (NASDAQ:BBIO)
ETF DAILY NEWS· 3 days agoAtria Wealth Solutions Inc. acquired a new position in shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO – Free Report) in the 4th quarter, according to the company in its most recent filing with ...
Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 17 hours agoCrinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Q1 2024 Earnings Call Transcript May 11, 2024...
The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
Investor's Business Daily· 5 days agoThe company is a leader in the neuroscience space. Neurocrine recently asked the Food and Drug...
